Status:
UNKNOWN
Assessment of Regional Response With PET-FDG in Advanced Head and Neck Squamous Cell Carcinoma
Lead Sponsor:
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Collaborating Sponsors:
Jules Bordet Institute
University of Liege
Conditions:
Head and Neck Squamous Cell Carcinoma
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Patients with advanced head and neck squamous cell carcinoma (HNSCC) may benefit from organ-preservation treatment based on combination of chemotherapy and radiotherapy without compromising disease-fr...
Detailed Description
\- The primary objective is to assess the negative predictive value (NPV) of PET as a single examination in correctly predicting the absence of remaining invaded lymph nodes after chemoradiotherapy fo...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Biopsy-proven HNSCC
- Clinical stage: unpreviously treated T1-T4 oral cavity, oropharynx, hypopharynx, larynx
- Only patients suitable for at least a neck dissection after chemoradiotherapy will be included. Consequently, inclusion criteria are thus : T1-T4 , N1 N2a, N2b N2c N3 M0.
- Patient scheduled for an organ preservation treatment protocol based on concomitant chemoradiation (induction chemotherapy is allowed if this approach is followed by concomitant chemoradiation)
Exclusion
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2012
Estimated Enrollment :
239 Patients enrolled
Trial Details
Trial ID
NCT00634777
Start Date
January 1 2007
End Date
January 1 2012
Last Update
July 20 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cliniques Universitaires Saint-Luc
Brussels, Belgium, 1200